Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,102
Total Claims
$1.6M
Drug Cost
889
Beneficiaries
$1,748
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+45%
Opioid rate vs peers
3.7% vs 2.6% avg
+64%
Cost per patient vs peers
$1,748 vs $1,068 avg
+48%
Brand preference vs peers
13.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.7%
Opioid Rate
638
Opioid Claims
$22K
Opioid Cost
6.1%
Long-Acting Rate
Brand vs Generic
Brand: 2,254 claims · $1.2M
Generic: 14,671 claims · $311K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 187 | $149K |
| Dapagliflozin Propanediol | 103 | $108K |
| Tirzepatide | 58 | $93K |
| Dulaglutide | 50 | $91K |
| Semaglutide | 58 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 75 | $54K |
| Fluticasone/Umeclidin/Vilanter | 46 | $51K |
| Empagliflozin | 45 | $45K |
| Insulin Aspart | 36 | $40K |
| Linaclotide | 47 | $38K |
| Insulin Lispro | 48 | $37K |
| Sitagliptin Phosphate | 25 | $33K |
| Linagliptin | 45 | $31K |
| Rivaroxaban | 34 | $31K |
| Insulin Detemir | 46 | $29K |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About